Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Annelise Capossela

The U.S. is about to pivot from hoarding vaccines to sharing them globally, and countries around the world are trying to secure their places in line.

Why it matters: President Biden has promised to donate 80 million doses by the end of June. With domestic demand waning, he’ll soon be able to offer far more. But the White House hasn't said how it will distribute the initial 80 million, or when it will feel comfortable truly opening its supply to the world.

The state of play: The U.S. is currently second only to China in terms of vaccine production, but had until recently been the only major producer to keep virtually its entire supply at home.

  • While more than half of all Americans have had at least one dose and dozens of rich countries aren't far behind, less than 1% of people across the world's low-income countries have been vaccinated.
  • With the U.S. set to belatedly become a global vaccine powerhouse, Biden has some high-stake decisions to make.

Zoom in: Facing a fast-unraveling domestic crisis fueled in part by the pandemic, Colombian Vice President Marta Lucía Ramírez traveled to Washington last week with an urgent request: access to some of the 80 million doses.

  • She’s not alone. Such requests have come in from all over the world, but countries in the Americas have been particularly frustrated with Biden's unwillingness to share up to now.
  • Most have purchased doses from Russia or China and some, like Mexico, have turned to both.
  • Ramírez told Axios that many of the vaccines Colombia has ordered aren’t expected until December, and the already hard-hit country is now seeing its worst spike yet.

The first decision Biden has to make is whether to send doses to individual countries, share in bulk through the WHO-backed COVAX initiative, or — as White House officials have indicated is most likely — pursue some combination of the two.

  • A European diplomat who spoke with Axios argued that the U.S. should reject “vaccine diplomacy” as practiced by Russia and China and bolster multilateralism by sharing with COVAX, which aims to provide every participating country with enough doses to cover 20% of its population this year.
  • Some countries are almost entirely reliant on COVAX, but export curbs from India have left the initiative months behind and with hardly any supply in the near term.

Yes, but: Experts including Zeke Emanuel, who served on Biden’s COVID-19 advisory board during the transition, argue that vaccines should be shipped where they’re urgently needed and can be readily distributed, not through COVAX’s population-based system.

  • And while Biden has said the U.S. donations will be driven by science and not geopolitics, there are clear soft power benefits to controlling distribution more directly.

What's next: In addition to the donations, producers like Pfizer and Moderna will be able to export U.S.-made doses once they've fulfilled their U.S. contracts. But many of those would be expected to go to rich countries with existing contracts.

  • Biden could exercise additional purchase options — including 300 million doses each from Pfizer and Moderna — to allow the government to choose the vaccines' destinations while also hedging against the need for boosters.

The big picture: 80 million doses is only a sliver of America’s supply, and a fraction of the global need.

  • “The real question is what threshold we’re going to use to start aggressively donating doses,” says Krishna Udayakumar, director of Duke University's Global Health Innovation Center.
  • Rather than stockpiling on shelves or in freezers, Udayakumar argues, the U.S. should donate rapidly now, with the knowledge that more supply will be available as new domestic needs arise.
  • The White House has sounded far more cautious, saying it wants to be "oversupplied and over-prepared" at home.

What to watch: Rich countries will control a huge chunk of global production even after their initial needs are met, and the U.S. has been the first to make such an ambitious pledge to share doses in the near term.

  • Watch for more pledges and more coordination between developed countries, including at the G7 summit in mid-June.

Go deeper

May 31, 2021 - Health

America's summer of normalcy

Illustration: Aïda Amer/Axios

Memorial Day marks the unofficial start to summer — and post-pandemic life.

The big picture: Even the most cautious Americans are beginning to shake off a lot of the isolation of the past year and live that “new normal” we’ve been talking about for so long.

May 31, 2021 - Health

Mobile COVID vaccination units head to rural communities and small towns

Mobile Vaccination Unit in Pennsylvania. Photo: Ben Hasty/MediaNews Group/Reading Eagle via Getty Images

Health officials across the United States are deploying mobile vaccination units in an effort to distribute COVID-19 vaccines to rural and other hard-to-reach communities.

Why it matters: As vaccination distribution slows nationwide, health officials are looking for ways to reach rural communities, homeless people and poorer Americans who can't take time off of work, lack child care or can't travel to vaccination sites, the New York Times reported.